Product Images Morphine Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Morphine Sulfate NDC 0832-0229 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - morphine 01

Chemical Structure - morphine 01

Figure 1 - morphine 02

Figure 1 - morphine 02

Figure 2 - morphine 03

Figure 2 - morphine 03

Figure 3 - morphine 04

Figure 3 - morphine 04

Figure 4 - morphine 05

Figure 4 - morphine 05

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - morphine 06

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - morphine 06

This is a description of Morphine Sulfate Extended-Release Capsules, which come in a 10mg dosage and are provided separately to each patient by a pharmacist. The capsules contain extended-release pellets, and should not be chemed, crushed or dissolved. The package should be stored between 20° to 25°C (66° to 77°F) and is light- and moisture-resistant. It should be kept out of reach of children and dispensed in a sealed, tamper-evident, child-resistant container. The manufacturer is Upsher-Smith Laboratories, LLC located in Maple Grove, MN. Full prescribing information can be found in the set package.*

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Bottle Label - morphine 07

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Bottle Label - morphine 07

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - morphine 08

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - morphine 08

This is a medicine package for Morphine Sulfate Extended-Release Capsules, USP with each capsule containing 30mg of morphine sulfate as extended-release pellets. Chewing, crushing or dissolving the pellets is NOT recommended. The usual dosage information is provided in the package insert. The package is child-resistant and should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (50-86°F). The medication must be kept away from moisture and light. A Medication Guide is provided separately with each patient's sealed, tamper-evident, and child-resistant container. This medicine should be dispensed by a pharmacist only and is manufactured by Upsher-Smith Laboratories, LLC.*

PRINCIPAL DISPLAY PANEL - 50 mg Capsule Bottle Label - morphine 09

PRINCIPAL DISPLAY PANEL - 50 mg Capsule Bottle Label - morphine 09

Morphine Sulfate Extended-Release Capsules, USP is a medication containing Morphine Sulfate USP of 50mg in an extended-release pellet form. The usual dosage should be taken as per the prescription. These pellets should not be chewed, crushed or dissolved. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F); excursions of 50 mg permitted to 15° to 30°C (50° to 86°F). The medication should be kept away from light and moisture. The Pharmacist should dispense the medication guide in a sealed, tamper-evident, child-resistant, provided separately to each patient. Keep out of reach of children. This medication comes in a pack of 100 capsules and is only available with a prescription. It is manufactured by Upsher-Smith Laboratories, LLC in Maple Grove, MN 55369 in the extended-release form to be taken once or twice daily.*

PRINCIPAL DISPLAY PANEL - 60 mg Capsule Bottle Label - morphine 10

PRINCIPAL DISPLAY PANEL - 60 mg Capsule Bottle Label - morphine 10

This is a medication called Morphine Sulfate Extended-Release Capsules, USP containing 60mg of morphine in extended-release pellets. The package comes with instructions for typical dosage but should not be chewed, crushed, or dissolved. The container is child-resistant and should be stored between 20° to 25°C (68° to 77°F), with excursions of up to 15° to 30°C (59° to 86°F) permitted. The medication should be protected from light and moisture and dispensed by a pharmacist. The container is tamper-resistant and light-resistant. The medication is only available through a prescription and manufactured by Upsher-Smith Laboratories, LLC in Maple Grove, MN.*

PRINCIPAL DISPLAY PANEL - 80 mg Capsule Bottle Label - morphine 11

PRINCIPAL DISPLAY PANEL - 80 mg Capsule Bottle Label - morphine 11

This is a medication information sheet for Morphine Sulfate Extended-Release Capsules, USP. Each capsule contains Morphine Sulfate, USP 80 mg as extended-release pellets. The recommended dosage should be followed as prescribed. The medication should not be chewed, crushed or dissolved. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F); excursions of 15° to 30°C (59° to 86°F) are permitted. The medication should be protected from light and moisture. The medication guide should be dispensed by the pharmacist in a sealed, tamper-evident, child-resistant container, provided separately to each patient. The medication should be kept out of reach of children. The manufacturer of the medication is Upsher-Smith Laboratories, LLC.*

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label - morphine 12

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label - morphine 12

Each capsule contains 100 mg of Morphine Sulfate USP as extended-release pellets. The capsules are not to be chewed but rather swallowed whole. The package is child-resistant and should be stored between 20-25°C (68°-77°F) with allowances for excursions of up to 15° to 30°C (59°-86°F). The medication is for use only in Opicid-tolerant patients and should be dispensed in a sealed, tamper-evident, child-resistant container. This medication should be kept out of the reach of children. For complete prescribing information, see the package insert. Manufactured by Upsher-Smith Laboratories, LLC.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.